PAI-1 and D-dimer in type 2 diabetic women with asymptomatic macrovascular disease assessed by carotid doppler

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 2, 2010, Pages 204-208

  Soares, Anna Letícia ^a   Wesley Rosário, Pedro ^b   Ribeiro Borges, Michelle Aparecida ^b   Oliveira Sousa, Marinez ^a   Moura Fernandes, Ana Paula Salles ^a   Carvalho, Maria Das Graças ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa de Misericórdia de Belo Horizonte Hospital   (Brazil)

Author keywords

Hypercoagulability; In vitro diagnostic systems; Type 2 diabetes

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL DIAMETER; CAROTID ARTERY; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STENOSIS;

EID: 77949883720     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609334626     Document Type: Article

References (13)

1. Juhan-Vague I., Alessi MC, Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med. 1996 ; 28 (4). 371-380.
2. Carr ME Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001 ; 15 (1). 44-54.
3. Meigs JB, ODonnell CJ, Tofler GH, et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006 ; 55 (2). 530-537.
4. Yamada T., Sato A., Nishimori T., et al. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes. Diabetes Res Clin Pract. 2000 ; 49 (1). 23-31.
5. Koerbel G., Korytkowski M. Coronary heart disease in women with diabetes. Diabetes Spectrum. 2003 ; 16 (3). 148-153.
6. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993 ; 88 (4 pt 1). 1999-2009.
7. Grant PJ Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007 ; 262 (2). 157-172.
8. Festa A., Williams K., Tracy RP, Wagenknecht LE, Haffner SM Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation. 2006 ; 113 (14). 1753-1759.
9. Vaughan DE PAI-1 and atherothrombosis. J Thromb Haemost. 2005 ; 3 (8). 1879-1883.
10. Wells PS Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost. 2007 ; 5 (suppl 1). 41-50.
11. Nwose EU, Richards RS, Jelinek HF, Kerr PG D-Dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications. Pathology. 2007 ; 39 (2). 252-257.
12. Matsuo T., Kobayashi H., Kario K., Suzuki S. Fibrin D-dimer in thrombogenic disorders. Semin Thromb Hemost. 2000 ; 26 (1). 101-107.
13. Sumida Y., Wada H., Fujii M., et al. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis. 1997 ; 8 (5). 303-307.